Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria.
Covira Surgical has raised $9.1M in total funding. The most recent round was Grant. The last funding was announced in October 2022.
Covira Surgical is headquartered in North Chicago, United States.
Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome's resident bacteria.
Covira Surgical is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Covira Surgical — Funding & Investors." VCBacked, October 6, 2022, https://www.vcbacked.co/company/covira-surgical. Accessed August 13, 2026.
VCBacked. (2022). Covira Surgical — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/covira-surgical
{{cite web |title=Covira Surgical — Funding & Investors |url=https://www.vcbacked.co/company/covira-surgical |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated